ClinicalTrials.gg
Not yet recruitingNCT07687381Updated Jul 8, 2026

AI-Based Reflective Parenting Simulation for Parents of Autistic Children

An interventional study of AI-Based Reflective Parenting Simulation in Autism Spectrum Disorder, sponsored by University of Haifa. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by University of Haifa · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial evaluates an AI-based parental simulation designed to support reflective parenting, emotional regulation, and parent-child communication among parents of autistic children aged 3 to 12 years. A total of 140 parents will be recruited through an external online survey platform and randomly assigned to an intervention group or a control group. The intervention group will complete baseline questionnaires, engage with the AI-based simulation, and then complete post-intervention measures. The control group will complete baseline and post-assessment measures before receiving access to the simulation.

Read the detailed description

The study examines the use of an AI-based parental simulation as a learning and reflective tool for parents of autistic children aged 3 to 12 years. The simulation is designed to allow parents to practice responses to emotionally challenging parent-child situations, with an emphasis on reflective functioning, emotional regulation, playfulness, and supportive parent-child communication.

Participants will be recruited through an external online survey platform and will provide informed consent before participation. After completing baseline questionnaires, participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will complete the AI-based simulation and then complete post-intervention measures. Participants in the control group will complete post-assessment measures before receiving access to the simulation.

02

Conditions studied

  • Autism Spectrum Disorder

Keywords

  • Parents of Autistic Children
  • Reflective Parenting
  • Parental Self-Efficacy
  • Emotion Regulation
  • Parent-Child Communication
  • AI-Based Simulation
03

In context

Autism Spectrum Disorder

1,724 studies on the registry are indexed under Autism Spectrum Disorder; 500 are open to participants now.

This study's planned enrollment of 140 is above the median of 52 across 1,368 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

University of Haifa is the lead sponsor of 105 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Parent or primary caregiver of an autistic child aged 3 to 12 years.
  • Child has a parent-reported diagnosis of Autism Spectrum Disorder.
  • Parent is 18 years of age or older.
  • Parent is able to read and complete questionnaires in Hebrew.
  • Parent has access to an internet-connected device and is able to complete the online study procedures.
  • Parent provides to participate.

Exclusion criteria

Exclusion Criteria:

  • - Parent does not provide .
  • Parent is not the parent or primary caregiver of an autistic child aged 3 to 12 years.
  • Parent is unable to complete the online questionnaires or the AI-based reflective parenting simulation.
  • Duplicate, incomplete, or low-quality responses that do not meet study quality criteria.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants in this group will complete the baseline questionnaire battery, including a study-specific 8-item evaluation questionnaire assessing four targeted domains: knowledge and understanding, parent-child communication skills, shared emotional regulation, and relational security. They will then engage with the AI-based therapeutic parental simulation and complete the same evaluation questionnaire again, followed by user experience and human-machine interaction questionnaires.

    Behavioral: AI-Based Reflective Parenting Simulation

  • No intervention
    Control Group

    Participants in this group will complete the baseline questionnaire battery, including a study-specific 8-item evaluation questionnaire assessing four targeted domains: knowledge and understanding, parent-child communication skills, shared emotional regulation, and relational security. They will then complete the same evaluation questionnaire again before receiving access to the AI-based therapeutic parental simulation. After using the simulation, they will complete user experience and human-machine interaction questionnaires.

Interventions

  • BehavioralAI-Based Reflective Parenting Simulation

    An AI-based reflective parenting simulation designed for parents of autistic children aged 3 to 12 years. The simulation allows parents to practice reflective, emotionally regulated, and supportive responses to challenging parent-child situations, with an emphasis on parent-child communication, shared emotional regulation, and the parent-child relationship as a secure anchor.

06

What researchers measure

Primary outcomes

  1. Change in Study-Specific Parent Reflective Capacity Questionnaire Score

    The study-specific Parent Reflective Capacity Questionnaire includes 8 items rated on a 1 to 5 scale. The questionnaire assesses parents' perceived capacity in four targeted domains: knowledge and understanding, parent-child communication skills, shared emotional regulation, and the parent-child relationship as a secure anchor. A total mean score will be calculated across the 8 items, with higher scores indicating higher perceived parental reflective capacity in the targeted domains.

    Time frame: Baseline and immediately after the intervention or control assessment point

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Oct 2026, 4 months later.

Of 800 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 4 months is below that.

Counting every sponsor, half of 823 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2026
First posted
Jul 7, 2026
StartEst.
Jun 30, 2026
Primary completionEst.
Oct 30, 2026
CompletionEst.
Jul 2027
Last update
Jul 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07687381
Responsible party
Sponsor
First posted
Jul 7, 2026
Start date
Jun 30, 2026 (estimated)
Primary completion
Oct 30, 2026 (estimated)
Completion
Jul 2027 (estimated)
Last update
Jul 8, 2026

Study contacts

Yael Enav, PhD
Contact
yaelenav@edu.haifa.ac.il
972-507261474

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion